Baird Expects FDA Rejection for Drisapersen and Eteplirsen (BMRN) (SRPT)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. COHR

Go back to Baird Expects FDA Rejection for Drisapersen and Eteplirsen (BMRN) (SRPT)
BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) Delayed: 64.06 +0.12 (0.19%)
Previous Close $63.94    52 Week High $108.96 
Open $64.35    52 Week Low $62.12 
Day High $64.96    P/E N/A 
Day Low $63.58    EPS $-1.27 
Volume 1,876,905       

SAREPTA THERAP (NASDAQ: SRPT) Delayed: 20.14 +0.03 (0.15%)
Previous Close $20.11    52 Week High $63.73 
Open $20.29    52 Week Low $8.00 
Day High $20.50    P/E N/A 
Day Low $19.97    EPS $-5.69 
Volume 1,756,520